MECP2 and Rett syndrome: Further evidence that peripherally derived hematopoietic cells can improve behavior was illustrated in a recent paper demonstrating that bone marrow transplant arrested disease development in MeCP2+/− mouse models of Rett's syndrome (Derecki et al., 2012).